-

Shareholder Alert: Robbins LLP Is Investigating Whether Officers and Directors of EQT Corporation (EQT) Misled Shareholders

SAN DIEGO & PITTSBURGH--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating certain officers and directors of EQT Corporation (NYSE: EQT) for breaches of their fiduciary duties and gross mismanagement. EQT is an energy company with an emphasis on Appalachian area natural gas supply, transmission and distribution.

If you suffered a loss due to EQT's misconduct, click here.

EQT Corporation (EQT) Allegedly Made False Statements About Its Acquisition of Rice Energy Inc.

On June 19, 2017, EQT announced that it had entered into an agreement to acquire rival gas producer Rice for $6.7 billion (the “Acquisition”). EQT asserted that, “by combining EQT’s and Rice’s contiguous acreage, EQT could drill natural-gas wells with longer laterals,” which EQT claimed would “generate cost savings and synergies amounting to at least $2.5 billion from the economies of scale that would result from drilling longer wells from the same well pads." The Acquisition closed on November 13, 2017.

On October 25, 2018, EQT disclosed shockingly bad financial results for the three months ended September 30, 2018, reporting an increase in capital expenditures for 2018 by $300 million to $2.5 billion and a quarterly net loss of $40 million. On an analyst and investor call that same day, EQT acknowledges it had not lived up to its prior statements about the Acquisition. On this news, EQT shares fell 13%, dropping from a close of $40.46 per share on October 24, 2018 to $35.34 on October 25, 2018, erasing nearly $700 million in shareholder value in a single day. Over the next several days, EQT shares fell to as low as $31.00 per share—less than half what the Company was worth when the Acquisition closed in November 2017.

On December 2, 2020, the U.S. District Court denied EQT's motion to dismiss a class action complaint alleging that EQT violated the Securities Exchange Act of 1934 in connection with statements made about the Acquisition, paving the way for litigation to proceed.

EQT Corporation (EQT) Shareholders Have Legal Options.

Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against EQT settles or to receive free alerts about companies engaged in wrongdoing, signup for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the REGENXBIO, Inc. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired REGENXBIO, Inc. (NASDAQ: RGNX) securities between February 9, 2022 and January 27, 2026. REGENXBIO is a clinical-stage biotechnology company providing gene therapies that deliver functional genes to cells with genetic defects in the United States. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800)...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...
Back to Newsroom